Symptomatic Expression and Psychopathological Features of the Personality by Borderline Subjects
Scharbach Hugues MD*
Paris’s University, National Expert : C.A.(Nancy, Rennes) & C. Cass.(Paris) Hon, Expert in Pharmacology Hon. Neuro-Psychiatrist Past head of Psychiatric Service in C.H.U, Doctor in Psychology’s, Lyon II Forensic Expert Hon, France
Submission:July 27, 2024; Published:August 07, 2024
*Corresponding author:Scharbach Hugues MD, Paris’s University Neuro-Psychiatrist Past head of Psychiatric Service in C.H.U, Doctor in Psychology’s, Lyon II Forensic Expert Hon, France
How to cite this article: Scharbach Hugues MD. Symptomatic Expression and Psychopathological Features of the Personality by Borderline Subjects. J of Pharmacol & Clin Res. 2024; 10(3): 555789. DOI: 10.19080/JPCR.2024.10.555789
Abstract
The progression of this psychiatric Troubles takes part of interest to the psychopathological exploration, of taking in consideration/account the distortions of Features of Personality, to importance of the Narcissistic problematic, to the possible disruption of comportment, to the loneliness’s Feeling may be in the background of “depressively”, to the great moment of anxiety’s occurrence, to the frequent association of Addictions.
Keywords: Psychopathology and nosography; Psychotherapists; Symptomatic Expression; Psychopathological Features
Introduction
I-Since around 50 years, Psychiatrists, Psychologists, psychotherapists wondered highlighting a grouping of disorders, the coherence of which did not find its place in the context of classification based on the criteria of both alienists as well as practitioners and psychanalysts relying on the research, the elaboration and theorizing of both S.FREUD (notably Oedipal conflict, Hans the Kid, The Wolf Man…), M. Klein (early processes of Identity building), Bowlby (attachment theory/ maternal deprivation, role of crucial bonds) and in 1980, a team leading by Robert Spitz in the frame of APA (American Psychiatric Association published the revised D.S.M., describing and classifying on statistical bases the mental trouble. (now D.S.M. 5-TR). II-This reference Manual should allow the discover and the implementation about this psychopathological concept difficult to be more accepted until then the opportunity to deepen the psychopathological aspects, particularly in the depressive register, did not escape psychoanalysts, like J. Bergeret in France and we had to highlight the frequency of the feeling of solitude in these subjects, who are sometimes quite enough chaotic in their interpersonal exchanges this new conception permits to be situated, overcoming the classical nosological level [1-6].
This emergence clinical taking in account the features of personality should modify a more adapted therapeutic Practice, notably in the register of narcissistic disturbances. Moreover, this new entity in research of categorization was even seeming to be encountered more frequently in the context of socio economic and cultural evolution, often including problems of addiction, food restriction, even suicide attempts in particular III-Psychopathological Configuration according to our Findings after a long Practice of nursing care and also in the frame of Forensic Expert Examination [7-15].
The Borderline Personalities or Limit Psychic States in France seem to be distributed along four Axes:
a) That has Prevalence of psychotic Traits according to Little in particular;
b) That of Borderline or anaclitic depressive personalities with inconsistency of the feeling of self-esteem linked to an insecure identity, a fluctuation of affects with recurrence of depressiveness, state of tenability or occurrence of moment of great anxiety emergence of anger and possible self- or hetero-aggressive acts [16-25].
c) That of personalities “as if “ with conventional and adaptative aspects to social norms, going hand in hand with a superficiality of affects giving rise to a resulting poverty of emotional life.
d) That with neurotic presentations, such as infantile or hysterical forms, as identified by O. Kernberg [25-31].
Main Psychopathological Aspects and Styles
i. More of less notable narcissistic Failures connoted by fragile Identity, affective-emotional weakness, avoid or loneliness feeling, anxiety, mood’s fluctuation, relative, bad control of emotion and of aggressivity, possible actings against himself, even violent acting reaching proof of its existence due to a fragile Identity; immature emotional development [31,33].
ii. Complex imaginary and possible odd fantasy, even with perverse connotations.
iii. Cahotic pulsional Organization.
iv. They could experiment a dependence on the other with a search for support, even promiscuity or “a contrario”, an intrusive perception of the other, possibly depending of the encounter [34].
Introduction
As had been written notably by H. Akiska (1981, 1983) about a population sample, it seems that the emotional disorders are frequent by borderline subjects, such emotional disturbances as well as depressive feelings appears, as well as instinctual troubles, such anorexia, disruptive conduct, facilitated by addictive behavior, disruptive comportment, poor impulse control, leading to possible hetero-aggressive acts or especially self-aggression such as self-harm or mutilation or suicide.
References
- Lin RR, Lin DA, Maderal (2024) AD Toxic Ingredients in Personal Care Products: A Dermatological Perspective. Dermatitis 35(2): 121-131.
- Hager E, Chen J, Zhao L (2022) Minireview: Parabens Exposure and Breast Cancer. Int J Environ Res Public Health 19(3): 1873.
- Schorr WF (1968) Paraben allergy. A cause of intractable dermatitis. JAMA 204(10): 859-862.
- Gershanik J (1982) The gasping syndrome and benzyl alcohol poisoning. N Engl J Med 307(22): 1384-1388.
- Liston AJ (1983) Toxic effects of benzyl alcohol. Can Med Assoc J 128(1): 8-13.
- Ivanovska V (2014) Pediatric drug formulations: a review of challenges and progress. Pediatrics 134(2): 361-372.
- Baudouin C (2010) Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res 29(4): 312-334.
- Goldstein MH (2022) Ocular benzalkonium chloride exposure: problems and solutions. Eye 36(2): 361-368.
- De Saint Jean M (1999) Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells. Invest Ophthalmol Vis Sci 40(3): 619-630.
- Whitson JT (2006) Assessment of corneal epithelial integrity after acute exposure to ocular hypotensive agents preserved with and without benzalkonium chloride. Adv Ther 23(5): 663-671.
- Beasley R, Rafferty P, Holgate ST (1988) Adverse reactions to the non-drug constituents of nebuliser solutions. Br J Clin Pharmacol 25(3): 283-287.
- Beasley R (1998) Preservatives in nebulizer solutions: risks without benefit. Pharmacotherapy 18(1): 130-139.
- Liebert M (1989) Final Report on the Safety Assessment of Benzalkonium Chloride. Journal of the American College of Toxicology 8(4): 589-625.
- Zheng G (2022) The first detection of quaternary ammonium compounds in breast milk: Implications for early-life exposure. J Expo Sci Environ Epidemiol 32(5): 682-688.
- (2006) U.E.P.A., Reregistration eligibility decision for alkyl dimethyl benzyl ammonium chloride (ADBAC). Environmental Protection Agency: Washington DC, USA
- (2017) European and Commission, Annex to the European Commission guideline on excipients in the labelling and package leaflet of medicinal products for human use (SANTE-2017-11668). European Commission: Brussels, Belgium.
- Vasdev N, Chauhari N, Rajpoot PA (2022) Current progress in preservative-free topical ophthalmic formulations. Journal of Drug Delivery Science and Technology.
- Figus M (2014) Bimatoprost 0.01% vs bimatoprost 0.03%: a 12-month prospective trial of clinical and in vivo confocal microscopy in glaucoma patients. Eye 28(4): 422-429.
- Easty DL (2006) Comparison of a non-preserved 0.1% T-Gel eye gel (single dose unit) with a preserved 0.1% T-Gel eye gel (multidose) in ocular hypertension and glaucomatous patients. Br J Ophthalmol 90(5): 574-578.
- Lewis RA (2007) Travoprost 0.004% with and without benzalkonium chloride: a comparison of safety and efficacy. J Glaucoma 16(1): 98-103.
- Gross RL (2008) Duration of IOP reduction with travoprost BAK-free solution. J Glaucoma 17(3): 217-222.
- Aptel F (2019) Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension. J Glaucoma 28(6): 498-506.
- Shedden A (2010) Comparison of the efficacy and tolerability of preservative-free and preservative-containing formulations of the dorzolamide/timolol fixed combination (COSOPT™) in patients with elevated intraocular pressure in a randomized clinical trial. Graefes Arch Clin Exp Ophthalmol 248(12): 1757-1764.
- Rosin LM, Bell NP (2013) Preservative toxicity in glaucoma medication: clinical evaluation of benzalkonium chloride-free 0.5% timolol eye drops. Clin Ophthalmol 7: 2131-2135.
- Baudouin C (2021) Inflammation in Glaucoma: From the back to the front of the eye, and beyond. Prog Retin Eye Res 83: 100916.
- (2023) Document FG Quality Considerations for Topical Ophthalmic Drug Products.
- Short FL (2021) Benzalkonium chloride antagonizes aminoglycoside antibiotics and promotes evolution of resistance. Ebio Medicine 73: 103653.
- Tatham AJ (2013) Eye drop instillation technique in patients with glaucoma. Eye 27(11): 1293-1298.
- Geyer O (1995) Microbial contamination of medications used to treat glaucoma. Br J Ophthalmol 79(4): 376-379.
- Teuchner B (2015) Microbial contamination of glaucoma eyedrops used by patients compared with ocular medications used in the hospital. Medicine (Baltimore) 94(8): e583.
- Kim S (2022) Comparison of a preservative-free nonsteroidal anti-inflammatory drug and preservative-free corticosteroid after uneventful cataract surgery: multicenter, randomized, evaluator-blinded clinical trial. J Cataract Refract Surg 48(6): 710-716.
- Maca SM (2010) Efficacy and tolerability of preservative-free and preserved diclofenac and preserved ketorolac eyedrops after cataract surgery. Am J Ophthalmol 149(5): 777-784.
- Broadway DC (1994) Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol 112(11): 1446-1454.
- Martone G (2009) An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology. Am J Ophthalmol 147(4): 725-735.
- Ammar DA, Noecker RJ, Kahook MY (2010) Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells. Adv Ther 27(11): 837-845.
- Goto Y, Ibaraki N, Miyake K (2003) Human lens epithelial cell damage and stimulation of their secretion of chemical mediators by benzalkonium chloride rather than latanoprost and timolol. Arch Ophthalmol 121(6): 835-839.
- Boimer C, Birt CM (2013) Preservative exposure and surgical outcomes in glaucoma patients: The PESO study. J Glaucoma 22(9): 730-735.
- Gomes JAP (2017) TFOS Dews II iatrogenic report. Ocul Surf 15(3): 511-538.
- Gomes JAP (2023) TFOS Lifestyle: Impact of elective medications and procedures on the ocular surface. Ocul Surf 29: 331-385.
- Muzyka Woźniak M, Stróżecki L, Przeździecka-Dołyk J (2023) Assessment of the eye surface and subjective symptoms after using 0.1% dexamethasone drops with and without preservatives in patients after cataract surgery. Sci Rep 13(1): 18625.
- (2024) Daily Med.
- Thygesen J (2018) Glaucoma therapy: preservative-free for all? Clin Ophthalmol 12: 707-717.